A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Clinical trial NCT06066138 · RECRUITING

Trial details

NCT number: NCT06066138
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced Alveolar Soft Part Sarcoma Metastatic Alveolar Soft Part Sarcoma Locally Advanced Non Small Cell Lung Cancer Metastatic Non Small Cell Lung Cancer Locally Advanced Small Cell Lung Cancer Metastatic Small Cell Lung Cancer Locally Advanced Hepatocellular Carcinoma Metastatic Hepatocellular Carcinoma Locally Advanced Melanoma Metastatic Melanoma

Start date: 2025-11-04
Primary completion: 2027-01-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.